中国卒中发病与费用的预测:2022至2050年
该研究基于全球疾病负担2021数据,以2021年为基线,采用指数增长模型预测2022至2050年中国缺血性卒中、脑出血和蛛网膜下腔出血的发病率和费用。
要点
- 费用日益集中于≥65岁人群,尤其≥85岁,且男性费用约为女性1.3倍。
核心结论
- 中国卒中的发病数和费用预计到2050年持续增长,主要由缺血性卒中和人口老龄化驱动。
研究设计与样本
- 基于全球疾病负担2021数据库,以2021年为基线,采用指数增长模型预测2022至2050年卒中发病率。
- 结合中国人口预测,使用确定性决策树模型估算12个月时间范围内的住院、直接医疗和社会成本。
主要发现
- 2050年缺血性卒中、脑出血和蛛网膜下腔出血发病数分别预计达7.89、1.59和0.11百万。
- 费用日益集中于≥65岁成人,尤其≥85岁;2050年男性卒中费用约为女性的1.3倍。
临床怎么用
- 需针对缺血性卒中和老年人群加强预防措施。
- 需规划面向老年人的医疗能力并制定长期融资策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke imposes a substantial and growing health and economic burden in China, yet forward-looking estimates of stroke-related costs remain scarce. METHODS: Annual age- and sex-specific incidence rates of ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage were projected from 2022 to 2050 using 2021 as the baseline year. Baseline incidence estimates were obtained from the Global Burden of Disease 2021 database, and future trends were projected using an exponential growth model parameterized by the average annual percent change estimated from 1990 to 2021 Global Burden of Disease data. Projected incidence rates were combined with China-specific population projections. A deterministic decision-tree model was used to estimate hospitalization costs, direct medical costs, and societal costs over a 12-month time horizon in China, using probabilities and unit costs from published literature. We used uncertainty intervals (UI) to quantify the plausible range of all projected outcomes. One-way sensitivity analyses were conducted to assess uncertainty in epidemiological and cost parameters. RESULTS: Total incident strokes are projected to increase from 4.35 million (95% UI, 3.09-5.89 million) in 2022 to 9.59 million (95% UI, 6.81-13.01 million) in 2050. By 2050, ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage incidences are projected to reach 7.89, 1.59, and 0.11 million, respectively. Total annual stroke hospitalization costs are projected to rise from $46.1 billion (95% UI, 44.94-47.24 billion) in 2022 to $91.2 billion (95% UI, 89.28-93.13 billion) in 2050; direct medical costs and societal costs are projected to increase from $67.6 billion to $133.9 billion and from $145.6 billion to $288.4 billion, respectively. Costs will be increasingly concentrated among adults aged ≥65 years, especially those aged ≥85 years. In 2050, stroke costs among men are projected to be approximately 1.3 times those for women. In sensitivity analyses incorporating incidence uncertainty, total annual hospitalization costs ranged from $39.9-$62.3 billion in 2022 to $65.0-$123.6 billion in 2050. CONCLUSIONS: Stroke incidence and costs in China are projected to increase through 2050, driven primarily by ischemic stroke and population aging, highlighting the need for targeted prevention, capacity planning for older adults, and long-term financing strategies.
引用
- Jiang Y, Xu L, Wang X, et al. Projection of Stroke Incidence and Costs in China: 2022 to 2050. Stroke. 2026. PMID: 42610235. doi:10.1161/STROKEAHA.125.054522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。